Karuna Therapeutics, Inc. Retained Earnings
Karuna Therapeutics, Inc. had Retained Earnings of -$997.89 million as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-02-22
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$997.89M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$884.06M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$764.94M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$661.78M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-12-31 | -$997.89M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$884.06M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$764.94M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$661.78M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$564.21M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$488.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$411.03M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$346.09M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$287.87M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$259.91M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$208.98M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$174.56M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$144.07M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$120.06M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$101.22M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$84.17M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$75.51M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$67.74M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$58.70M 10-Q · filed 2019-08-08 |
| 2018-12-31 | -$31.55M 10-K · filed 2020-03-24 |